Manufacturing Challenges And Strategies For Autologous Gene Modified Cell Therapies

Time: 3:30 pm
day: Day Two


  • This presentation will aim to outline the challenges of commercial manufacture and release of Autologous Gene Therapies
  • The presentation will explain how solutions such as use of high throughput analytics will complicate the logistics whilst also increasing the cost of goods
  • The risks involved in the solution of technically upskilling the commercial workforce by means of apprenticeship schemes will also be challenged
  • Strategies of introducing mature solutions from sectors outside of Pharmaceuticals and Life Sciences will be discussed